T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$841M |
| 2 |
Liberty Global Class C
LBTYK
|
+$752M |
| 3 |
Apple
AAPL
|
+$720M |
| 4 |
Tesla
TSLA
|
+$713M |
| 5 |
NXP Semiconductors
NXPI
|
+$648M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.2B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.03B |
| 3 |
Gilead Sciences
GILD
|
+$917M |
| 4 |
Pfizer
PFE
|
+$901M |
| 5 |
Nike
NKE
|
+$872M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.88% |
| 2 | Consumer Discretionary | 14.86% |
| 3 | Financials | 14.2% |
| 4 | Technology | 12.51% |
| 5 | Industrials | 9.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NATI
451
DELISTED
National Instruments Corp
NATI
| $168M | 0.04% |
6,128,972
+2,558,963
| +72% | +$71.3M |
|
452
Alexandria Real Estate Equities
ARE
$8.33B
| $167M | 0.04% |
1,608,553
+279,118
| +21% | +$26.6M |
|
|
FLTX
453
DELISTED
Fleetmatics Group PLC
FLTX
| $165M | 0.04% |
3,808,243
-83,040
| -2% | -$3.31M |
|
454
Sun Life Financial
SLF
$44.8B
| $164M | 0.03% |
5,016,000
-1,533,085
| -23% | -$51.4M |
|
455
WIX.com
WIX
$3.35B
| $159M | 0.03% |
5,250,706
+1,686,290
| +47% | +$43M |
|
|
NEWR
456
DELISTED
New Relic, Inc.
NEWR
| $158M | 0.03% |
5,386,828
+524,799
| +11% | +$14.4M |
|
457
Teledyne Technologies
TDY
$31.2B
| $158M | 0.03% |
1,594,630
+146,837
| +10% | +$13.9M |
|
458
Highwoods Properties
HIW
$3.51B
| $156M | 0.03% |
2,962,821
-64,882
| -2% | -$3.12M |
|
459
Cintas
CTAS
$80.3B
| $156M | 0.03% |
6,362,668
-201,476
| -3% | -$4.64M |
|
460
Haemonetics
HAE
$4.11B
| $156M | 0.03% |
5,371,130
+708,620
| +15% | +$21.4M |
|
461
Semtech
SMTC
$12.4B
| $155M | 0.03% |
6,493,060
-1,317,660
| -17% | -$29.9M |
|
462
Liberty Global Class A
LBTYA
$3.58B
| $154M | 0.03% |
5,301,431
-1,040,166
| -16% | -$33.8M |
|
463
Webster Financial
WBS
$12.8B
| $153M | 0.03% |
4,510,142
+1,583,172
| +54% | +$57.7M |
|
464
Cognizant
CTSH
$26.7B
| $153M | 0.03% |
2,665,959
-395,108
| -13% | -$23.9M |
|
465
Scholastic
SCHL
$784M
| $152M | 0.03% |
3,842,431
-49,700
| -1% | -$1.87M |
|
|
CKH
466
DELISTED
Seacor Holdings Inc.
CKH
| $152M | 0.03% |
2,705,003
-18,178
| -0.7% | -$999K |
|
|
PRA
467
DELISTED
ProAssurance
PRA
| $151M | 0.03% |
2,822,945
-581,744
| -17% | -$29.2M |
|
468
Ecolab
ECL
$77.4B
| $150M | 0.03% |
1,264,078
+10,546
| +0.8% | +$1.23M |
|
469
Bright Horizons
BFAM
$3.85B
| $150M | 0.03% |
2,258,519
+1,971
| +0.1% | +$128K |
|
470
Pacira BioSciences
PCRX
$924M
| $149M | 0.03% |
4,431,743
+298,369
| +7% | +$14.7M |
|
|
SGEN
471
DELISTED
Seagen Inc. Common Stock
SGEN
| $149M | 0.03% |
3,689,989
-5,964
| -0.2% | -$227K |
|
472
Host Hotels & Resorts
HST
$15.6B
| $149M | 0.03% |
9,179,900
-215,230
| -2% | -$3.39M |
|
|
WBC
473
DELISTED
WABCO HOLDINGS INC.
WBC
| $148M | 0.03% |
1,614,278
+4,892
| +0.3% | +$518K |
|
474
Terreno Realty
TRNO
$7.5B
| $147M | 0.03% |
5,686,120
+17,100
| +0.3% | +$406K |
|
475
Halliburton
HAL
$27.4B
| $146M | 0.03% |
3,230,155
-3,103,873
| -49% | -$128M |
|
Similar funds
T. Rowe Price Associates's Q2 2016 Portfolio in Review
As of Q2 2016, T. Rowe Price Associates held 2,596 positions worth $472B, up 0.75% from $468B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q2 2016 filing shows 95 new, 1,094 increased, 954 reduced and 84 closed positions. Its largest new stake was American Tower Corporation: 2,223,765 shares worth $246M. The largest sale was Alexion Pharmaceuticals, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2016 buy was American Tower Corporation: 2,223,765 shares worth $246M.
- T. Rowe Price Associates added most to Mondelez International in Q2 2016, an estimated $841M increase.
- T. Rowe Price Associates's biggest Q2 2016 reduction was Alexion Pharmaceuticals, cutting an estimated $1.2B.
- T. Rowe Price Associates fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $750M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $472B portfolio in Q2 2016.
- T. Rowe Price Associates opened 95 new positions and closed 84 in Q2 2016.
- T. Rowe Price Associates's portfolio value rose 0.75% quarter-over-quarter to $472B.
Based on T. Rowe Price Associates's 13F filing for Q2 2016, filed 15 Aug 2016.